What Happened
- World Wildlife Day was observed on 3 March 2026 with the theme "Medicinal and Aromatic Plants: Conserving Health, Heritage and Livelihoods."
- The theme drew global attention to the accelerating threat of overharvesting and habitat loss facing the 50,000–70,000 medicinal and aromatic plant (MAP) species used worldwide.
- CITES (Convention on International Trade in Endangered Species) organised a virtual global celebration, highlighting the more than 1,500 MAP species regulated under its framework.
- Over 20% of plant species used for medicinal and aromatic purposes are now considered threatened with extinction on the IUCN Red List.
- In India, the day prompted attention to the country's extraordinary MAP biodiversity — estimated at 15,000 medicinal plant species across 45,000 total plant species.
Static Topic Bridges
World Wildlife Day and CITES: Origins and Framework
World Wildlife Day is observed every year on 3 March to raise awareness of the world's wild flora and fauna. The date commemorates the signing of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) on 3 March 1973 in Washington, D.C. The UN General Assembly proclaimed 3 March as World Wildlife Day in December 2013.
- CITES membership: 184 parties (countries) — one of the largest conservation agreements by membership.
- CITES regulates international trade in ~38,000 species through three appendices:
- Appendix I: Species threatened with extinction; commercial trade prohibited (e.g., tiger, elephant, rhinos).
- Appendix II: Not yet threatened but could become so; trade permitted with permits (e.g., most coral, many orchids).
- Appendix III: Protected in at least one country; co-operation requested of other parties.
- Over 1,500 MAP species are listed under CITES appendices; trade in these requires export permits.
- CITES does not regulate in-country trade or habitat destruction — only cross-border commercial trade.
Connection to this news: The 2026 WWD theme focuses on medicinal plants because their international trade — largely unregulated or poorly monitored — is a primary driver of population decline for several hundred plant species, precisely the gap CITES was designed to address.
IUCN Red List Categories and Medicinal Plant Threats
The IUCN Red List uses a nine-category system to assess species extinction risk. For medicinal plants, the most relevant categories are Critically Endangered (CR), Endangered (EN), and Vulnerable (VU), which together constitute the "threatened" designations. Over 20% of the approximately 50,000–70,000 MAP species harvested globally fall in these categories.
- IUCN Red List categories: EX (Extinct), EW (Extinct in the Wild), CR (Critically Endangered), EN (Endangered), VU (Vulnerable), NT (Near Threatened), LC (Least Concern).
- Nardostachys jatamansi (Spikenard): Himalayan herb used in Ayurveda — Critically Endangered; trade restrictions now apply in Nepal.
- Primary threats to MAP species: overharvesting from wild populations, habitat conversion, climate change, and lack of cultivation alternatives.
- An estimated 15,000 medicinal plant species globally are at risk of extinction from overharvesting according to WWF and Plantlife International.
Connection to this news: The 2026 WWD theme's focus on MAP species reflects IUCN data showing these plants are among the fastest-declining flora categories — their extinction risk is driven by demand from pharmaceutical, herbal, and cosmetic industries combined with inadequate cultivation infrastructure.
India's Medicinal Plant Heritage and Conservation Policy
India is one of the world's mega-biodiversity hotspots, with 15 agro-climatic regions supporting approximately 45,000 plant species, of which 15,000 are known for medicinal properties. Nearly 70% of India's MAP species are in the tropical forests of the Western Ghats, Eastern Ghats, and Himalayas. India's traditional medicine systems — Ayurveda, Siddha, Unani, and Yoga — depend on this plant biodiversity.
- National Medicinal Plants Board (NMPB): established under the Ministry of AYUSH, runs dedicated schemes for conservation and sustainable management of medicinal plants.
- 115 Medicinal Plants Conservation Area (MPCA) sites operate across India as in-situ conservation models.
- Biological Diversity Act 2002: governs access and benefit-sharing for biological resources; National Biodiversity Authority (NBA) implements it.
- India's AYUSH sector: growing at ~17% annually; estimated market size of $18 billion — but most raw material is wild-harvested, not cultivated.
- Nagoya Protocol on Access and Benefit Sharing (2010): India ratified it; ensures traditional knowledge holders benefit from commercial use of their biodiversity.
Connection to this news: India's extraordinary MAP biodiversity makes it both a key target of global conservation attention and a major stakeholder in sustainable trade regulation — World Wildlife Day 2026's theme directly aligns with India's policy priorities under AYUSH and the Biological Diversity framework.
Key Facts & Data
- World Wildlife Day: 3 March annually; commemorates CITES adoption on 3 March 1973.
- WWD 2026 theme: "Medicinal and Aromatic Plants: Conserving Health, Heritage and Livelihoods."
- MAP species harvested globally: 50,000–70,000; over 20% threatened with IUCN extinction risk.
- MAP species under CITES: over 1,500.
- India's medicinal plant biodiversity: ~15,000 species (out of 45,000 total plant species); 8,000 in active use in traditional systems.
- NMPB: 115 MPCA sites for in-situ conservation across India.
- Biological Diversity Act 2002: India's primary legislation governing biodiversity access and benefit-sharing.
- CITES parties: 184 countries; three appendices covering ~38,000 species of flora and fauna.
- Indian AYUSH market: ~$18 billion, growing at ~17% annually — primarily dependent on wild-harvested MAP species.